老年心力衰竭患者在医院和初级保健互动中揭示了影响坚持的上下文因素:一项描述性研究
Herman Bjørnstad1,2, Christine Frigaard1,2, Pål Gulbrandsen1,2
1Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Patient preference and adherence
|April 21, 2025
概括
老年心力衰竭患者在从医院到家庭过渡期间面临着坚持挑战. 关键障碍包括药物副作用和复杂性,而知识和社会支持可以促进遵守.
科学领域:
- 老年医学 老年医学
- 心脏病学 心脏病学
- 健康心理学 心理健康心理学
背景情况:
- 患有心力衰竭的老年患者是医院到家庭过渡期间的脆弱群体.
- 诸如态度和社会支持等非生物医学因素 (上下文因素) 影响治疗坚持.
- 这些因素在临床相互作用中的表现仍然不太清楚.
研究的目的:
- 识别和描述如何以及何时非生物医学因素出现在临床相互作用.
- 在老年心力衰竭患者的医院到家庭过渡的背景下分析这些因素.
主要方法:
- 在医院到家庭的过渡互动期间录制了42名老年心力衰竭患者的音频.
- 利用一项综合性审查,创建了48个影响守的因素列表.
- 从患者的发言中提取和分类上下文指标 (CI).
主要成果:
- 在105个记录中确定了742个上下文指标 (CI),平均每次互动有7个CI.
- 确定了坚持的障碍 (58%) 和促进者 (42%).
- 突出的障碍包括药物副作用和治疗方案的复杂性;促进者包括知识,动机和社会支持.
结论:
- 临床医生应解决患者对药物副作用和治疗方案复杂性的担忧.
- 利用患者的知识,动力和社会支持可以提高治疗的坚持.
- 了解非生物医学因素对于改善心力衰竭患者的护理过渡至关重要.
相关概念视频
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Assessment of the Cardiovascular System I: Subjective Data
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...


